WallStSmart

Addus HomeCare Corporation (ADUS)vsThe Ensign Group Inc (ENSG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Ensign Group Inc generates 256% more annual revenue ($5.06B vs $1.42B). ENSG leads profitability with a 6.8% profit margin vs 6.7%. ADUS appears more attractively valued with a PEG of 0.97. ADUS earns a higher WallStSmart Score of 70/100 (B).

ADUS

Strong Buy

70

out of 100

Grade: B

Growth: 8.7Profit: 5.5Value: 10.0Quality: 6.3
Piotroski: 2/9Altman Z: 3.11

ENSG

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 6.0Value: 8.0Quality: 5.8
Piotroski: 5/9Altman Z: 2.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ADUSUndervalued (+53.9%)

Margin of Safety

+53.9%

Fair Value

$244.30

Current Price

$99.31

$144.99 discount

UndervaluedFair: $244.30Overvalued
ENSGFair Value (-0.1%)

Margin of Safety

-0.1%

Fair Value

$211.64

Current Price

$202.92

$8.72 premium

UndervaluedFair: $211.64Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ADUS5 strengths · Avg: 8.8/10
EPS GrowthGrowth
52.1%10/10

Earnings expanding 52.1% YoY

Altman Z-ScoreHealth
3.1110/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.978/10

Growing faster than its price suggests

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
25.6%8/10

Revenue surging 25.6% year-over-year

ENSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
20.2%8/10

Revenue surging 20.2% year-over-year

Areas to Watch

ADUS4 concerns · Avg: 2.8/10
Market CapQuality
$1.85B3/10

Smaller company, higher risk/reward

Profit MarginProfitability
6.7%3/10

6.7% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Free Cash FlowQuality
$02/10

Negative free cash flow — burning cash

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.804/10

Expensive relative to growth rate

P/E RatioValuation
34.3x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
6.8%3/10

6.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ADUS

The strongest argument for ADUS centers on EPS Growth, Altman Z-Score, PEG Ratio. Revenue growth of 25.6% demonstrates continued momentum. PEG of 0.97 suggests the stock is reasonably priced for its growth.

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.

Bear Case : ADUS

The primary concerns for ADUS are Market Cap, Profit Margin, Piotroski F-Score.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Key Dynamics to Monitor

ADUS carries more volatility with a beta of 0.93 — expect wider price swings.

ADUS is growing revenue faster at 25.6% — sustainability is the question.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ADUS scores higher overall (70/100 vs 57/100) and 25.6% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Addus HomeCare Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Addus HomeCare Corporation, provides personal care services to the elderly, the chronically ill, the disabled, and people who are at risk of hospitalization or institutionalization in the United States. The company is headquartered in Frisco, Texas.

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Want to dig deeper into these stocks?